您的位置: 首页 > 农业专利 > 详情页

6-oxo-1,6-dihydropyridazine derivative for use in the treatment of hepatocellular carcinoma (hcc)
专利权人:
MERCK PATENT GMBH
发明人:
FRIEDHEIM BLADT,MANJA FRIESE-HAMIM
申请号:
BR112015008279
公开号:
BR112015008279A2
申请日:
2013.10.04
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
patent summary: "6-oxo-1,6-dihydro-pyridazine derivative for use in the treatment of hepatocellular carcinoma (hcc)". The present invention relates to 3- (1- {3- [5- (1-methyl-piperidin-4-ylmethoxy) -pyrimidin-2-yl] -benzyl} -6-oxo-1,6-dihydroxyamide). hydro-pyridazin-3-yl) benzonitrile or a pharmaceutically acceptable salt and / or solvate thereof for use for the treatment of hepatocellular carcinoma (hcc).resumo patente de invenção: "derivado de 6-oxo-1,6-di-hidro-piridazina para uso no tratamento de carcinoma hepatocelular (hcc)". a presente invenção refere-se a 3-(1-{3-[5-(1-metil-piperidin-4-ilmetóxi)-pirimidin-2-il]-benzil}-6-oxo-1,6-di-hidro-piridazin-3-il)-benzonitrila ou um sal e/ou solvato farmaceuticamente aceitável da mesma para uso para o tratamento de carcinoma hepatocelular (hcc).
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充